WO2023058000 - PLATFORM FOR IDENTIFYING NOVEL ANALGESIC THERAPIES
National phase entry:
Publication Number
WO/2023/058000
Publication Date
13.04.2023
International Application No.
PCT/IB2022/059656
International Filing Date
08.10.2022
Title **
[English]
PLATFORM FOR IDENTIFYING NOVEL ANALGESIC THERAPIES
[French]
PLATEFORME D'IDENTIFICATION DE NOUVELLES THÉRAPIES ANALGÉSIQUES
Applicants **
EPTIVA THERAPEUTICS LTD.
1132 Gidley Way
Horpath
Oxford OX33 1TD, GB
Inventors
FIELD, Mark J.
73 Springfields, Great Dunmow
Essex Essex CM6 1BS, GB
Priority Data
63/253,619
08.10.2021
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1230 | |
| EPO | Filing, Examination | 6000 | |
| Japan | Filing | 589 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2710 |
Total: 11104 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present disclosure is directed to a platform for linking therapeutic compounds to pain phenotypes/conditions and thereby identifying potential novel analgesic therapies. The platform can generate patient selection criteria and/or identify a subset of patients that would be suitable for a clinical trial related to the selected therapeutic compound and the one or more identified pain phenotypes/conditions.[French]
La présente divulgation est relative à une plateforme permettant de lier des composés thérapeutiques à des phénotypes/états de douleur et ainsi d'identifier de nouvelles thérapies analgésiques potentielles. La plateforme peut générer des critères de sélection de patient et/ou identifier un sous-ensemble de patients qui pourraient participer à un essai clinique lié au composé thérapeutique sélectionné et aux phénotypes/états de douleur identifiés.